Yuval Cabilliy

Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY.

GT Nexus, Inc. provides cloud based collaboration platform across trade communities. Its solutions include supply chain intelligence, supply chain visibility, factory management, transportation management, inventory management, supply collaboration, procure to pay, supply chain finance and trade express. The firm engages in manufacturing, retail, logistics services, financial services and suppliers. The company was founded by Aaron Omid Sasson, Vijay Sundaram, Greg Johnsen and Anil Nair in 1998 and is headquartered in Oakland, CA.

Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Yeda Research & Development Co. Ltd. engages in development of natural science and services. It covers broad of spectrum including: biotechnology, pharmaceuticals and diagnostics, bioinformatics, proteomics, biomatics and system biology, medical devices, renewable energy, bio fuels, clean technology and environmental sciences, agricultural and plants genetics, chemistry and nanotechnology, physics and electro-optics, mathematics and computer science. The company is headquartered in Rehovot, Israel.

Conquer Cancer Foundation of the American Society of Clinical Oncology operates as a non-profit organization that researches in the prevention, treatment, and cure of cancer. Its programs include health information technology platform; patient resources; online medical education; and meetings, symposia, and workshop. The company was founded in 1964 and is headquartered in Alexandria, VA.

Metallo Therapy Ltd. is an Israeli start-up that engages in developing novel contrast agents that enable precise tumor detection and monitoring using the CT imaging tool. The company was founded in 2009 by Amal Ayoub and is headquartered in Nazareth Illit, Israel.

Israel Advanced Technology Industries is an umbrella organization that represents the high-tech, life science, and other advanced technology industries. The private company is based in Hertzliya Pituach, Israel. The Israeli company was founded by Nechemia Jacob Peres, Aaron Mankovski, and Ruth Alon. The CEO is Karin Meir Rubinstein.

Metabomed Ltd. operates as a drug discovery company. It focuses in the field of cancer metabolism with a proprietary target identification platform based on computational biology and metabolomics. The company was founded by Eytan Ruppin, Tomer Shlomi and Eyal Gottlieb in 2013 and is headquartered in Yavne, Israel.

Lanetix, Inc. develops software tools. It offers CRM and workflow software for the logistics industry, helping logistics service providers (LSPs) streamline their bid desks, increase margin, improve sales productivity and reduce risk in solution design and delivery. The firm offers services to freight forwarding, ocean carrier, freight brokerage and 3PL/value added warehousing companies. The company was founded by John Golob, Troy Goode, Natasha Oxenburgh and Aaron Omid Sasson in 2013 and is headquartered in

Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel.

Ram Technologies Ltd. is an Irish private company located in Meath. The firm provides IT services.

Censa Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes therapeutics for orphan central nervous system disorders. The company was founded by Christopher Schelling in 2015 and is headquartered in Wellesley, MA.

PhotonPharma, Inc. is developing the Innocell therapeutic cancer vaccine, which is a personalized therapy using autologous tumor tissue. The company is based in Fort Collins, CO at the Research Innovation Center of Colorado State University. The technology is based on a photochemical inactivation platform that uses riboflavin (vitamin B2) and UV light to render tumor cells incapable of replication while still allowing them to metabolize, express proteins, present antigens, and stimulate immune recognition and response mechanisms. In combination with selected adjuvants, Innocell has shown the ability to prevent metastatic tumor formation, reduce tumor growth, and stimulate cellular immune response pathways in preclinical animal models. The company was founded in 2018 by Raymond Goodrich, and Alan S. Rudolph has been the CEO since 2018.